98 related articles for article (PubMed ID: 1476877)
1. Characterization of the mucosal immune response to 2-acetylaminofluorene-protein conjugates.
Silbart LK; Keren DF; McDonald RA; Lincoln PM; Goslinoski L; Smart JB
Reg Immunol; 1992; 4(4):245-54. PubMed ID: 1476877
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of mucosal immune responses to 2-acetylaminofluorene.
Silbart LK; McAleer F; Rasmussen MV; Goslinoski L; Keren DF; Finley A; Van Kruiningen HJ; Winchell JM
Anticancer Res; 1996; 16(2):651-60. PubMed ID: 8687111
[TBL] [Abstract][Full Text] [Related]
3. Reduction of intestinal carcinogen absorption by carcinogen-specific secretory immunity.
Silbart LK; Keren DF
Science; 1989 Mar; 243(4897):1462-4. PubMed ID: 2928780
[TBL] [Abstract][Full Text] [Related]
4. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
5. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.
Lycke N; Erlandsson L; Ekman L; Schön K; Leanderson T
J Immunol; 1999 Jul; 163(2):913-9. PubMed ID: 10395687
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
8. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
[TBL] [Abstract][Full Text] [Related]
9. Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin.
Navarro-García F; Pedroso M; López-Revilla R
Clin Immunol; 2000 Nov; 97(2):182-8. PubMed ID: 11027459
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.
Hajishengallis G; Hollingshead SK; Koga T; Russell MW
J Immunol; 1995 May; 154(9):4322-32. PubMed ID: 7722290
[TBL] [Abstract][Full Text] [Related]
12. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice.
Bianchi AT; Zwart RJ; Van der Heijden PJ
Reg Immunol; 1990-1991; 3(3):131-8. PubMed ID: 2098068
[TBL] [Abstract][Full Text] [Related]
13. Local (immunoglobulin A) immune response by the intestine to cholera toxin and its partial suppression with combined systemic and intra-intestinal immunization.
Yardley JH; Keren DF; Hamilton SR; Brown GD
Infect Immun; 1978 Feb; 19(2):589-97. PubMed ID: 631891
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
[TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immune response to an HIV C4/V3 peptide following nasal or intestinal immunization of rabbits.
Winchell JM; Van Kruiningen HJ; Silbart LK
AIDS Res Hum Retroviruses; 1997 Jul; 13(10):881-9. PubMed ID: 9197382
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates.
Kubota M; Miller CJ; Imaoka K; Kawabata S; Fujihashi K; McGhee JR; Kiyono H
J Immunol; 1997 Jun; 158(11):5321-9. PubMed ID: 9164952
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
Israf DA; Lajis NH; Somchit MN; Sulaiman MR
Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
[TBL] [Abstract][Full Text] [Related]
19. Morphological and immune response alterations in the intestinal mucosa of the mouse after short periods on a low-magnesium diet.
Zimowska W; Girardeau JP; Kuryszko J; Bayle D; Rayssiguier Y; Mazur A
Br J Nutr; 2002 Nov; 88(5):515-22. PubMed ID: 12425732
[TBL] [Abstract][Full Text] [Related]
20. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
